The regenerative medicine market in India is on the rise as technology is developing; there is an increase in demand for innovative treatment, and rise in chronic diseases. This sector is estimated to grow at a CAGR of over 20 percent and in fact, will play a big role in the country’s healthcare landscape. This novel approach fills a critical need for treating diseases such as cardiovascular diseases, diabetes, neurodegenerative disorders, and orthopedic injuries, providing promise for treatment of patients with conditions once thought to be untreatable or life limiting. The... >>More
Dheeraj Jain, Founder, Redcliffe Labs
Kshitij Rishi, Co-Founder & COO, 4basecare
Saji Mathew, Chief Operating Officer, Baby Memorial Hospital
Hiren Mehta, Vice President (Clinical Affairs), Veeda Clinical Research, India
Dr. Shirish Alurkar, Sr. Consultant - Medical Oncology, HCG Cancer Centre